1-(1-phenethylpiperidin-4-yl)-1-phenylethanois as potent and highly selective 5-HT2A antagonists

被引:13
作者
Heinrich, Timo
Boettcher, Henning
Pruecher, Helmut
Gottschlich, Rudolf
Ackermann, Karl-August
van Amsterdam, Christoph
机构
[1] Merck KGaA, Preclinical Pharmaceutical Research, 64293 Darmstadt
关键词
Insomnia; Medicinal chemistry; Neurotransmitters; Schizophrenia; Serotonin;
D O I
10.1002/cmdc.200500023
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The discovery of a novel class of highly potent and selective 5-HT2A antagonists is reported herein. Selectivity for the serotonin 5-HT2A receptor was optimized, decreasing the affinity of these antagonists toward the adrenergic alpha(1) and dopaminergic D-2 receptors, and especially to the 5-HT2C receptor. A series of corresponding 7-substituted indoles is described for the first time as serotonergic ligands. The enantiomer R-(+)-1-(4-fluoropheny1)-1-{1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl} ethanol (R-(+)-74) was identified to have superior affinity for the serotonergic 5-HT2A receptor [IC50=0.37nm] and selectivity toward the dopaminergic D-2- [IC50=2300 nm], adrenergic alpha(1)- [IC50 = 1000 nm] and 5-HT2C receptors [IC50 = 490 nm].
引用
收藏
页码:245 / 255
页数:11
相关论文
共 57 条
[1]  
ADACHI M, 1985, CHEM PHARM BULL, V33, P1826
[2]  
AGHAJANIAN GK, 1990, ANN NY ACAD SCI, V600, P93
[3]  
*AV SA, 2004, CO PRES
[4]   Pharmacological manipulation of human working memory [J].
Barch, DM .
PSYCHOPHARMACOLOGY, 2004, 174 (01) :126-135
[5]   EMD 281014, a new selective serotonin 5-HT2A receptor antagonist [J].
Bartoszyk, GD ;
van Amsterdam, C ;
Böttcher, H ;
Seyfried, CA .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 473 (2-3) :229-230
[6]  
BINA AG, Patent No. 9946245
[7]  
Blank T, 1996, J NEUROSCI RES, V45, P153, DOI 10.1002/(SICI)1097-4547(19960715)45:2<153::AID-JNR7>3.0.CO
[8]  
2-9
[9]   THE PHARMACOLOGY AND DISTRIBUTION OF HUMAN 5-HYDROXYTRYPTAMINE(2B) (5-HT2B) RECEPTOR GENE-PRODUCTS - COMPARISON WITH 5-HT2A AND 5-HT2C RECEPTORS [J].
BONHAUS, DW ;
BACH, C ;
DESOUZA, A ;
SALAZAR, FHR ;
MATSUOKA, BD ;
ZUPPAN, P ;
CHAN, HW ;
EGLEN, RM .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 115 (04) :622-628
[10]  
de Paulis T, 2001, Curr Opin Investig Drugs, V2, P123